The global Hemato-Oncology Testing Market is anticipated to experience robust growth, with a compound annual growth rate (CAGR) of 18.5%. Starting from a value of US$ 4.33 billion in 2023, it is forecasted to reach US$ 23.64 billion by 2033. Within hematology oncology tests, there are distinct categories such as services, assay kits, and reagents. The demand for assay kits and reagents is...